NASDAQ Health Care Index (IXHC) Companies by Market Cap
The NASDAQ Health Care Index (IXHC) tracks 976 constituent companies with a combined market cap of $2.62 Trillion, covering the largest publicly traded companies in USA. This ranking lists all IXHC index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$2.62 Trillion
Constituent Companies
976
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 101 |
LivaNova PLC
NASDAQ:LIVN |
% | $4.20 Billion | Healthcare | Medical Devices | $76.39 | +0.63% |
| 102 |
Metsera, Inc. Common Stock
NASDAQ:MTSR |
% | $4.12 Billion | Healthcare | Biotechnology | $70.50 | +0.00% |
| 103 |
Premier Inc
NASDAQ:PINC |
% | $4.06 Billion | Healthcare | Health Information Services | $49.15 | +0.02% |
| 104 |
Tango Therapeutics Inc
NASDAQ:TNGX |
% | $4.01 Billion | Healthcare | Biotechnology | $23.81 | +5.49% |
| 105 |
Indivior PLC Ordinary Shares
NASDAQ:INDV |
% | $3.91 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $35.83 | +1.07% |
| 106 |
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX |
% | $3.85 Billion | Healthcare | Biotechnology | $31.49 | +0.00% |
| 107 |
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA |
% | $3.85 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $79.78 | +1.31% |
| 108 |
Pulse Biosciences Inc
NASDAQ:PLSE |
% | $3.79 Billion | Healthcare | Medical Instruments & Supplies | $53.81 | +7.66% |
| 109 |
Edgewise Therapeutics Inc
NASDAQ:EWTX |
% | $3.66 Billion | Healthcare | Biotechnology | $39.06 | -0.43% |
| 110 |
Legend Biotech Corp
NASDAQ:LEGN |
% | $3.62 Billion | Healthcare | Biotechnology | $18.62 | -0.48% |
| 111 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX |
% | $3.57 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $12.18 | +2.01% |
| 112 |
SpringWorks Therapeutics Inc
NASDAQ:SWTX |
% | $3.54 Billion | Healthcare | Biotechnology | $46.99 | +0.00% |
| 113 |
Abcellera Biologics Inc
NASDAQ:ABCL |
% | $3.53 Billion | Healthcare | Biotechnology | $12.55 | +4.37% |
| 114 |
Viking Therapeutics Inc
NASDAQ:VKTX |
% | $3.53 Billion | Healthcare | Biotechnology | $28.51 | +2.81% |
| 115 |
iRhythm Technologies Inc
NASDAQ:IRTC |
% | $3.51 Billion | Healthcare | Medical Devices | $106.70 | +4.00% |
| 116 |
Ideaya Biosciences Inc
NASDAQ:IDYA |
% | $3.48 Billion | Healthcare | Biotechnology | $36.11 | +0.14% |
| 117 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
% | $3.41 Billion | Healthcare | Biotechnology | $19.78 | +1.02% |
| 118 |
GRAIL, LLC
NASDAQ:GRAL |
% | $3.40 Billion | Healthcare | Diagnostics & Research | $140.58 | +6.01% |
| 119 |
Veracyte Inc
NASDAQ:VCYT |
% | $3.38 Billion | Healthcare | Diagnostics & Research | $45.23 | +3.74% |
| 120 |
Amedisys Inc
NASDAQ:AMED |
% | $3.32 Billion | Healthcare | Medical Care Facilities | $100.99 | +0.00% |
| 121 |
Tarsus Pharmaceuticals Inc
NASDAQ:TARS |
% | $3.21 Billion | Healthcare | Biotechnology | $73.16 | +1.30% |
| 122 |
CorVel Corp
NASDAQ:CRVL |
% | $3.17 Billion | Financial Services | Insurance Brokers | $77.16 | +1.06% |
| 123 |
Celcuity LLC
NASDAQ:CELC |
% | $3.14 Billion | Healthcare | Biotechnology | $67.94 | +0.10% |
| 124 |
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX |
% | $3.14 Billion | Healthcare | Biotechnology | $28.14 | +3.46% |
| 125 |
Denali Therapeutics Inc
NASDAQ:DNLI |
% | $3.11 Billion | Healthcare | Biotechnology | $19.45 | +4.18% |
| 126 |
ICU Medical Inc
NASDAQ:ICUI |
% | $3.11 Billion | Healthcare | Medical Instruments & Supplies | $160.32 | +2.00% |
| 127 |
Arcutis Biotherapeutics Inc
NASDAQ:ARQT |
% | $3.07 Billion | Healthcare | Biotechnology | $26.58 | +8.53% |
| 128 |
Enliven Therapeutics Inc.
NASDAQ:ELVN |
% | $3.00 Billion | Healthcare | Biotechnology | $40.98 | +0.86% |
| 129 |
Relay Therapeutics Inc
NASDAQ:RLAY |
% | $2.95 Billion | Healthcare | Biotechnology | $17.88 | +2.70% |
| 130 |
Xenon Pharmaceuticals Inc
NASDAQ:XENE |
% | $2.82 Billion | Healthcare | Biotechnology | $36.44 | +0.77% |
| 131 |
Zai Lab Ltd
NASDAQ:ZLAB |
% | $2.81 Billion | Healthcare | Biotechnology | $24.99 | +0.73% |
| 132 |
Soleno Therapeutics Inc
NASDAQ:SLNO |
% | $2.76 Billion | Healthcare | Biotechnology | $53.01 | +0.00% |
| 133 |
Dyne Therapeutics Inc
NASDAQ:DYN |
% | $2.75 Billion | Healthcare | Biotechnology | $16.64 | +1.65% |
| 134 |
Regencell Bioscience Holdings Ltd
NASDAQ:RGC |
% | $2.72 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $7.35 | -3.67% |
| 135 |
TransMedics Group Inc
NASDAQ:TMDX |
% | $2.70 Billion | Healthcare | Medical Devices | $77.87 | -1.43% |
| 136 |
ATAI Life Sciences BV
NASDAQ:ATAI |
% | $2.69 Billion | Healthcare | Biotechnology | $7.35 | +0.00% |
| 137 |
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH |
% | $2.67 Billion | Healthcare | Medical Care Facilities | $12.25 | +0.08% |
| 138 |
Beam Therapeutics Inc
NASDAQ:BEAM |
% | $2.60 Billion | Healthcare | Biotechnology | $25.70 | +4.47% |
| 139 |
CareDx Inc
NASDAQ:CDNA |
% | $2.59 Billion | Healthcare | Diagnostics & Research | $63.67 | +2.36% |
| 140 |
Privia Health Group Inc
NASDAQ:PRVA |
% | $2.58 Billion | Healthcare | Health Information Services | $20.85 | +3.27% |
| 141 |
Neogen Corporation
NASDAQ:NEOG |
% | $2.55 Billion | Healthcare | Diagnostics & Research | $11.85 | +1.20% |
| 142 |
Supernus Pharmaceuticals Inc
NASDAQ:SUPN |
% | $2.48 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $42.67 | +1.26% |
| 143 |
Liquidia Technologies Inc
NASDAQ:LQDA |
% | $2.45 Billion | Healthcare | Biotechnology | $27.38 | -2.28% |
| 144 |
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ:NAMS |
% | $2.45 Billion | Healthcare | Biotechnology | $21.58 | +1.48% |
| 145 |
Precigen Inc
NASDAQ:PGEN |
% | $2.43 Billion | Healthcare | Biotechnology | $7.81 | +2.76% |
| 146 |
Adaptive Biotechnologies Corp
NASDAQ:ADPT |
% | $2.43 Billion | Healthcare | Biotechnology | $26.49 | +1.53% |
| 147 |
Disc Medicine Inc.
NASDAQ:IRON |
% | $2.38 Billion | Healthcare | Biotechnology | $62.06 | +2.12% |
| 148 |
Sellas Life Sciences Group Inc
NASDAQ:SLS |
% | $2.35 Billion | Healthcare | Biotechnology | $11.65 | +3.46% |
| 149 |
Celldex Therapeutics Inc
NASDAQ:CLDX |
% | $2.35 Billion | Healthcare | Biotechnology | $29.89 | +2.01% |
| 150 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
% | $2.35 Billion | Healthcare | Biotechnology | $40.28 | +1.72% |
Complete list of all companies in the IXHC index ranked by market capitalization. Track index constituent performance and market values. View all indices